Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Price:
39.48
USD
-0.7%
Market Closed
Market Cap:
$5.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
UK |
|
Blue Biofuels Inc
OTC:BIOF
|
US |
|
C
|
Cargotec Corp
OMXH:CGCBV
|
FI |
|
M
|
Mars Acquisition Corp
NASDAQ:MARX
|
US |
|
O
|
Orosur Mining Inc
XBER:UR2
|
CA |
|
D
|
Donkeyrepublic Holding A/S
CSE:DONKEY
|
DK |
|
C
|
Cresco Labs Inc
CNSX:CL
|
US |
Balance Sheet
Balance Sheet Decomposition
Centessa Pharmaceuticals PLC
Centessa Pharmaceuticals PLC
Balance Sheet Decomposition is not available for
Centessa Pharmaceuticals PLC
Centessa Pharmaceuticals PLC
Balance Sheet
Centessa Pharmaceuticals PLC
Centessa Pharmaceuticals PLC
Currency: USD
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
17
|
7
|
595
|
394
|
128
|
383
|
61
|
|
| Cash |
17
|
7
|
595
|
394
|
128
|
383
|
61
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
129
|
99
|
233
|
|
| Total Receivables |
2
|
3
|
17
|
27
|
39
|
45
|
60
|
|
| Other Current Assets |
1
|
1
|
17
|
17
|
19
|
9
|
13
|
|
| Total Current Assets |
19
|
11
|
629
|
438
|
315
|
536
|
368
|
|
| PP&E Net |
0
|
0
|
0
|
1
|
13
|
12
|
11
|
|
| PP&E Gross |
0
|
0
|
0
|
1
|
13
|
12
|
11
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Note Receivable |
1
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
283
|
|
| Other Long-Term Assets |
0
|
0
|
1
|
5
|
32
|
29
|
26
|
|
| Total Assets |
20
N/A
|
12
-41%
|
630
+5 281%
|
444
-29%
|
360
-19%
|
577
+60%
|
687
+19%
|
|
| Liabilities | ||||||||
| Accounts Payable |
1
|
1
|
8
|
14
|
12
|
7
|
8
|
|
| Accrued Liabilities |
0
|
1
|
16
|
23
|
27
|
50
|
35
|
|
| Short-Term Debt |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
5
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
1
|
1
|
2
|
0
|
1
|
0
|
|
| Total Current Liabilities |
2
|
9
|
25
|
38
|
39
|
58
|
43
|
|
| Long-Term Debt |
4
|
0
|
76
|
70
|
76
|
109
|
110
|
|
| Other Liabilities |
1
|
0
|
38
|
0
|
9
|
8
|
8
|
|
| Total Liabilities |
6
N/A
|
9
+41%
|
138
+1 506%
|
108
-22%
|
124
+15%
|
175
+41%
|
161
-8%
|
|
| Equity | ||||||||
| Common Stock |
26
|
26
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
13
|
23
|
386
|
602
|
753
|
989
|
1 186
|
|
| Additional Paid In Capital |
0
|
0
|
876
|
939
|
987
|
1 386
|
1 710
|
|
| Other Equity |
1
|
0
|
1
|
2
|
1
|
4
|
3
|
|
| Total Equity |
14
N/A
|
3
-77%
|
492
+15 758%
|
336
-32%
|
236
-30%
|
402
+70%
|
527
+31%
|
|
| Total Liabilities & Equity |
20
N/A
|
12
-41%
|
630
+5 281%
|
444
-29%
|
360
-19%
|
577
+60%
|
687
+19%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
87
|
87
|
90
|
95
|
99
|
133
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
